Live feed
Filing
SC 13G
SC 13G0001104659-21-022568·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
CERECOR INC
Security class unavailable · CUSIP: 15671L109
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,233,316
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-022568
- Form type
- SC 13G
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Feb 16, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership